Browsing by Author Bardy, P G

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2013Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trialBradstock, Kenneth; Chen, Sharon; Sorrell, Tania; Bajel, Ashish; Bardy, P G; et al, Various; Gilroy, Nicole M.; Guy, Stephen; Halliday, Catriona; Milliken, Samuel; Moore, John; Morrissey, C. O.; Schwarer, Anthony; Szer, Jeffrey; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium InstituteGalactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial, Lancet Infectious Diseases, vol.13, 6, 2013,pp 519-528
2013Polymorphism in Human Cytomegalovirus UL40 Impacts on Recognition of Human Leukocyte Antigen-E (HLA-E) by Natural Killer CellsBradstock, Kenneth; Bardy, P G; et al, Various; Harpur, Christopher; Heatley, Susan; Lester, Susan; Lin, Jie; Pietra, Gabriella; Rossjohn, Jamie; Schwarer, Anthony; Szer, J.; Widjaja, Jacqueline; Western Clinical School: Westmead Millennium InstitutePolymorphism in Human Cytomegalovirus UL40 Impacts on Recognition of Human Leukocyte Antigen-E (HLA-E) by Natural Killer Cells, The Journal of Biological Chemistry, vol.288, 12, 2013,pp 8679-8690
2007A prospective multicenter trial of peripheral blood stem cell sibling allografts for acute myeloid leukemia in first complete remission using fludarabine-cyclophosphamide reduced intensity conditioningBradstock, Kenneth; Gibson, John; Bardy, P G; Grigg, Andrew P.; Kennedy, Gregor; Koelmeyer, R L; Reynolds, John; Roberts, A W; Shuttleworth, P; Szer, J.; To, L B; Western Clinical School: Westmead Millennium Institute; Central Clinical School: MedicineA prospective multicenter trial of peripheral blood stem cell sibling allografts for acute myeloid leukemia in first complete remission using fludarabine-cyclophosphamide reduced intensity conditioning, Biology Of Blood And Marrow Transplantation, vol.13,(5),2007,pp 560-567